Familial aggregation of early- and late-onset Parkinson's disease

Annals of Neurology

Volumn 54, Issue 4, 2003, Pages 507-513

  Marder, Karen ^a,b   Levy, Gilberto ^b   Louis, Elan D ^a,b   Mejia Santana, Helen ^a,b   Cote, Lucien ^a   Andrews, Howard ^a,b   Harris, Juliette ^a   Waters, Cheryl ^a   Ford, Blair ^a   Frucht, Steven ^a   Fahn, Stanley ^a   Ottman, Ruth ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETIC ASSOCIATION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARENT; PARKINSON DISEASE; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; SIBLING;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; DEMOGRAPHY; FAMILY; FAMILY HEALTH; HUMANS; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; QUESTIONNAIRES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0141535355     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10711     Document Type: Article

References (52)

1. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43: 1173-1180.
2. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661.
3. Bonifati V, Fabrizio E, Vanacore N, et al. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci 1995;22: 272-279.
4. Marder K, Tang M-X, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996;47:155-160.
5. De Michele G, Filla A, Volpe G, et al. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord 1996;11:17-23.
6. Taylor CA, Saint-Hilaire MH, Cupples LA, et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Gen 1999;88:742-749.
7. Autere JM, Moilanen JS, Myllyla VV, Majamaa K. Familial aggregation of Parkinson's disease in a Finnish population. J Neurol Neurosurg Psychiatry 2000;69:107-109.
8. Zorzon M, Capus L, Pellegrino A, et al. Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy. Acta Neurol Scand 2002;105:77-82.
9. Elbaz A, Grigoletto F, Baldereschi M, et al. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 1999;52:1876-1882.
10. Rybicki BA, Johnson CC, Peterson EL, et al. A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology 1999;18:270-278.
11. Payami H, Zareparsi S, James D, Nutt J. Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 2002;59:848-850.
12. Sveinbjornsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 2000; 343:1765-1770.
13. Hicks AA, Petursson H, Thorlakur J, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002; 52:549-555.
14. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-346.
15. Piccini P, Burn DJ, Ceravolo R, et al. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999;45: 577-582.
16. Polymeropoulos M, Higgins J, Golbe L, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-1199.
17. Matsumine H, Saito M, Shimoda-Matsubayashi S, et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.-27. Am J Hum Genet 1997;60:588-596.
18. Valente EM, Brancati F, Ferraris A, et al. PARK6-linked parkinsonism occurs in several European families. Ann Neurol 2002;51:14-18.
19. Farrer M, Gwinn-Hardy K, Muenter M, et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 1999;8:81-85.
20. van Duijn CM, Dekker MC, Bonifati V, et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001;69:629-634.
21. Bonifati V, Breedveld GJ, Squitieri F, et al. Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset. Ann Neurol 2002; 51:253-256.
22. West AB, Zimprich A, Lockhart PJ, et al. Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur J Hum Genet 2001;9:659-666.
23. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
24. Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2q13.1. Ann Neurol 2002;51:296-301.
25. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990;40:1529-1534.
26. Hughes AJ, Ben-Schlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42: 1142-1146.
27. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psych 1992;55:181-184.
28. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. In: Streiffler MB, Korczyn AD, Melamed E, Youdim MB, editors. Parkinson's disease: anatomy, pathology and therapy. New York: Raven Press, 1990:245-249.
29. de Rijk MC, Rocca WA, Anderson DW, et al. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997;48:1277-1281.
30. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992; 49:492-497.
31. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998;147:259-268.
32. Louis ED, Zheng W, Jurewicz EC, et al. Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 2002;59: 1940-1944.
33. Marder K, Levy G, Louis ED, et al. Accuracy of family history data on Parkinson's disease. Neurology 2003;61:18-23.
34. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychi Neuropsychol Behav Neurol 1988;1:111-117.
35. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1981.
36. Fahn S, Marsden C, Calne D. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987.
37. Louis ED, Barnes L, Wendt KJ, et al. A teaching videotape for the assessment of essential tremor. Mov Disord 2001;16: 89-93.
38. Stern Y, Sano M, Paulson J, Mayeux R. Modified mini-mental state examination: validity and reliability. Neurology 1987; 37(suppl 1):179.
39. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992;49: 453-460.
40. Marder K, Tang M-X, Cote L, et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695-701.
41. Jacobs DM, Marder K, Cote LJ, et al. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 1995;45:1691-1696.
42. Tang M-X, Tsai W-Y, Marder K, Mayeux R. Linear rank tests for doubly censored data. Stat Med 1995;14:2555-2563.
43. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the a-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
44. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.. Nature 1998;392:605-608.
45. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
46. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-259.
47. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-1567.
48. Hedrich K, Marder K, Harris J, et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 2002;58:1239-1246.
49. Foroud T, Uniacke SK, Liu X, et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology 2003:796-801.
50. Roy M, Boyer L, Barbeau A. A prospective study of 50 cases of familial Parkinson's disease. Can J Neurol Sci 1983;10:37-42.
51. Barbeau A, Pourcher E. New data on the genetics of Parkinson's disease. Can J Neurol Sci 1982;9:53-60.
52. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-526.